Amniocentesis: Detecting Fetal Defects & Chromosomal Abnormalities
Amniocentesis is a prenatal diagnostic procedure that involves withdrawing a small sample of amniotic fluid from the amniotic sac surrounding the developing fetus. This fluid contains fetal cells and various substances that provide valuable information about the baby's health. The test is typically performed between 15 and 20 weeks of pregnancy and can detect a wide range of conditions.
Conditions Detected by Amniocentesis
1. Neural Tube Defects (NTDs)
Amniocentesis can identify NTDs such as spina bifida and anencephaly, which result from incomplete closure of the neural tube during early fetal development. Elevated levels of alpha-fetoprotein (AFP) in the amniotic fluid often signal these defects.
2. Chromosomal Abnormalities
The test can diagnose chromosomal disorders caused by extra or missing chromosomes, including:
- Down syndrome (Trisomy 21)
- Trisomy 18 (Edwards syndrome)
- Trisomy 13 (Patau syndrome)
- Sex chromosome abnormalities (e.g., Turner syndrome, Klinefelter syndrome)
3. Genetic Disorders
If there is a known family history or carrier status, amniocentesis can test for specific single-gene disorders such as:
- Cystic fibrosis
- Sickle cell anemia
- Tay-Sachs disease
- Muscular dystrophy
4. Fetal Infections
The procedure can detect certain intrauterine infections that may affect the fetus, including:
- Cytomegalovirus (CMV)
- Toxoplasmosis
- Rubella
- Parvovirus B19
5. Fetal Lung Maturity
In pregnancies where preterm delivery is being considered (usually after 32 weeks), amniocentesis can assess lung maturity by measuring the ratio of lecithin to sphingomyelin (L/S ratio) and the presence of phosphatidylglycerol in the amniotic fluid.
6. Rh Incompatibility
For Rh-negative mothers carrying an Rh-positive fetus, amniocentesis can monitor bilirubin levels in the amniotic fluid to assess the severity of fetal anemia due to Rh sensitization.
Procedure, Risks, and Considerations
Amniocentesis is generally safe but carries a small risk of complications, including:
- Leakage of amniotic fluid (1–2%)
- Miscarriage (approximately 0.1–0.3% risk)
- Infection (rare)
- Rh sensitization in Rh-negative mothers (prevented with Rh immunoglobulin)
The decision to undergo amniocentesis should be made after thorough discussion with your healthcare provider or a genetic counselor, weighing the benefits of diagnostic certainty against the procedural risks. Non-invasive prenatal testing (NIPT) is now available as a screening option, but amniocentesis remains the gold standard for definitive diagnosis.
Infertility - Related Articles
- Endometriosis Activity Independent of Menstruation: Hormonal Drivers and Clinical Implications
- Pregnancy After Tubal Ligation: Rare but Possible
- Understanding Artificial Insemination: Types, Procedures & When It's Used
- Pregnancy Test Timing: When to Test After Ovulation
- Scrotal Swelling After Abdominal Paracentesis: Causes, Symptoms & Management
- Ultrasound Gender Prediction: Signs, Accuracy & Limitations
- Male Pregnancy: Understanding Why It's Not Possible for Teen Boys
